As healthcare providers face the long-term revenue compression of COVID-19, they’re also navigating significant industry changes. Current challenges include horizontal competition from large insurers and digital disrupters, growing telehealth volumes, headwinds from price transparency, and growth in managed care programs, like Medicare Advantage. Without restored or growing volumes, how do health systems return to profitability?
Health systems will need accurate financial data around service line and procedural profitability, which very few have. Allocations, estimates and averages of cost, and large pools of clinical “overhead” are inaccurate, and these methods have no credibility with physicians and administrators.
Join Rob DeMichiei, Strategic Advisor for Health Catalyst and former Executive Vice President and Chief Financial Officer for UPMC, to learn more.
What You’ll Learn:
- How insurers look at their medical expenses, and their plans to reduce utilization and steer volumes away from traditional providers.
- The implications of price transparency; why a rational pricing strategy is critical to success.
- Using existing EHR data to measure and assess 100 percent of your clinical costs.
- How improved costing enables service-line management and allows for improved clinical care delivery and insight into profitability.
- How activity-based costing can help identify physician and clinical variation.
- Implications of inaccurate RVU/RCC costing on contract negotiations, resource management, and productivity reporting.
- Benefits and simplicity of activity-based (consumption) costing.
VIP Call Girls Noida Jhanvi 9711199171 Best VIP Call Girls Near Me
Will the Revenue Ever Return? COVID-19 and the Rise of the Insurers; the Case for Operational and Cost Transformation
1. Will the Revenue Ever Return?
COVID-19 and the Rise of the Insurers;
the Case for Operational and Cost
Transformation
Robert A. DeMichiei – Strategic Advisor, Health Catalyst;
Retired EVP and CFO, UPMC
March 31, 2021